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ABSTRACT Calsequestrin, the major calcium sequestering protein in the sarcoplasmic reticulum of muscle, forms a quaternary
complex with the ryanodine receptor calcium release channel and the intrinsic membrane proteins triadin and junctin. We have
investigated the possibility that calsequestrin is a luminal calcium concentration sensor for the ryanodine receptor. We measured
the luminal calcium concentration atwhich calsequestrin dissociates from the ryanodine receptor and the effect of calsequestrin on
the response of the ryanodine receptor to changes in luminal calcium.We provide electrophysiological and biochemical evidence
that: 1), luminal calciumconcentration of$4mMdissociates calsequestrin from junctional facemembrane, whereas in the rangeof
1–3mMcalsequestrin remains attached; 2), the association with calsequestrin inhibits ryanodine receptor activity, but ampliﬁes its
response to changes in luminal calcium concentration; and 3), under physiological calcium conditions (1 mM), phosphorylation of
calsequestrin does not alter its ability to inhibit native ryanodine receptor activity when the anchoring proteins triadin and junctin are
present. These data suggest that the quaternary complex is intact in vivo, and provides further evidence that calsequestrin is
involved in the sarcoplasmic reticulum calcium signaling pathway and has a role as a luminal calcium sensor for the ryanodine
receptor.
INTRODUCTION
In skeletal muscle, Ca21 release through the sarcoplasmic
reticulum (SR) Ca21 release channel, the ryanodine receptor
(RyR), triggers muscle contraction. The RyR is known to
associate with other proteins, such as the FK506-binding
protein, DHPR, triadin, junctin, and calsequestrin (CSQ),
forming a large macromolecular complex in the junctional
SR membrane (Meissner, 2004). CSQ, the major Ca21
binding protein within the SR lumen is located in the direct
vicinity of the RyR1 (Franzini-Armstrong et al., 1987), binds
triadin and junctin (Guo and Campbell, 1995; Guo et al.,
1994; Jones et al., 1995), and presumably these proteins
form a quaternary complex that controls Ca21 release (Wang
et al., 1998; Yano and Zarain-Herzberg, 1994). Both triadin
and junctin span the SR membrane and are the only proteins
known to associate with both the RyR and CSQ (Brandt et al.,
1990; Groh et al., 1999; Guo and Campbell, 1995; Kim and
Caswell, 1990; Kobayashi et al., 2000; Zhang et al., 1997),
thus providing the physical link between the RyR and CSQ.
Although CSQ was thought to have the main role of
maintaining Ca21 homeostasis and providing Ca21 for
release by the RyR, recent reports have demonstrated its
regulatory ability on both native RyRs, presumably by
binding to coproteins triadin and junctin on the luminal side
of the channel complex (Beard et al., 2002; Gyo¨rke et al.,
2004; Wang et al., 2001), and puriﬁed RyR channel activity,
by binding directly to the luminal portion of the RyR
(Szegedi et al., 1999). Therefore, CSQ is ideally placed to act
as a sensor for luminal [Ca21] in the transduction pathway
linking RyR activity with store load.
The release of Ca21 from the SR is strongly dependent on
the SR Ca21 load (Gyo¨rke et al., 2002; Lamb et al., 2001).
Thismay be in part due to the electrochemical driving force on
Ca21 ions, although this is unlikely to be a major factor
because the free [Ca21] is strongly buffered at ;1 mM by
CSQ (Fryer and Stephenson, 1996). Amore important feature
is the ability of luminal [Ca21] to regulate single RyR channel
activity (Fill et al., 1990; Herrmann-Frank and Lehmann-
Horn, 1996; Ma et al., 1988; Sitsapesan and Williams, 1995;
Szegedi et al., 1999; Tripathy and Meissner, 1996), via Ca21
sensors associated with luminal domains of the RyR (Ching
et al., 2000), one of which is likely to be CSQ (Gyo¨rke and
Gyo¨rke, 1998). However, CSQ can only function in this
capacity if it is physically coupled to the RyR at the normal
free luminal [Ca21] of ;1 mM. CSQ could act as a Ca21
sensor because many of its properties are Ca21 dependent.
Ca21 is important in stabilizing both the polymer structure
of CSQ and the quaternary complex (Wang et al., 1998),
whereas CSQ binding to junctin and triadin is inhibited in
the presence of .10 mM Ca21 (Zhang et al., 1997).
Our recent data suggest that CSQ is associated with the
RyR when the free luminal [Ca21] is 1 mM. Raising luminal
Ca21 from 1 to 13 mM increases RyR activity in two phases
(Beard et al., 2002). Firstly, an initial fast phase, which ismost
likely due to direct Ca21 activation of theRyR (at cytoplasmic
and/or luminal sites). Secondly, a slower phase is likely to be
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due to CSQ dissociation and hence the removal of CSQs
inhibitory effect. These results are in contrast to other studies
that suggest that CSQ may be dissociated from triadin and
junctin with 1 mM luminal [Ca21] (Shin et al., 2000). To
determine more precisely the luminal [Ca21] at which CSQ
dissociates and whether or not CSQ is associated with the
RyR/triadin/junctin (RyR/T/J) complex in working muscle,
the effect of varying luminal [Ca21] between 1 and 5 mM has
been examined and is reported here. In addition, we explore
the possibility that CSQ communicates changes in luminal
[Ca21] to the RyR. We have also investigated the effects of
CSQ phosphorylation on its inhibition of native RyRs (where
both triadin and junctin are present) and the interaction with
these anchoring proteins, at 1 mM Ca21. The results show
that: a), CSQ remains associated with the junctional face
membrane in the presence of 1 and 2 mMCa21, but that CSQ
is removed from native RyRs when luminal Ca21 is increased
to 4 mM; b), the presence of CSQ ampliﬁes the response of
native RyRs to changes in luminal [Ca21]; c), phosphoryla-
tion of CSQ does not inﬂuence CSQs ability to inhibit native
RyRs at a physiological [Ca21]; and d), phosphorylation of
CSQ does not alter the physical coupling between CSQ and
triadin and junctin in an in vivo environment.
MATERIALS AND METHODS
Materials
The polyclonal anti-CSQ antibody was obtained from Swant Chemicals
(Bellinzona, Switzerland), whereas both the monoclonal VD111D12 (anti-
CSQ) antibody and anti-phosphothreonine antibody was obtained from Bio




Back and leg muscles were removed from New Zealand white rabbits and
SR vesicles prepared using methods of Saito et al. (1984), with minor
changes (Ahern et al., 1994).
Junctional face membrane
Junctional face membrane was isolated from either heavy SR (Kim et al.,
1983), or SR vesicles as previously described (Costello et al., 1986), with
minor changes (Beard, 2003).
Calsequestrin puriﬁcation from rabbit skeletal muscle
CSQ was puriﬁed from RyR-enriched SR, using the methodology reported
previously (Costello et al., 1986), except that centrifugation after solubili-
zation was performed at 48,000 3 g for 1 h (Professor Cecilia Hidalgo,
Instituto de Ciencias Biomedicas, Universidad de Chile, Santiago, Chile, per-
sonal communication).
To determine the effect of [Ca21] on CSQ dissociation from junctional
face membrane, the concentration of junctional face membrane was adjusted
to 3.3 mg/ml by the addition of 230 mM Cs methanesulfonate (CsMS),
20 mM CsCl, 1 mM CaCl2, 10 mM TES (which corresponds to the solu-
tion used in single channel recordings; see below), with 0.5% triton X-100,
0.4 mM benzamidine, and 1 mg/ml leupeptin. After incubation on ice for
30 min and centrifugation at 100,000 3 g for 15 min, the solubilized junc-
tional face membrane pellet was suspended at 5 mg/ml, in 230 mM CsMS,
20 mM CsCl, 1 mM CaCl2, 10 mM TES, 0.5% triton X-100, 0.4 mM
benzamidine, and 1 mg/ml leupeptin. The ﬁnal [Ca21] was adjusted to 1, 2,
3, 4, 5, or 10 mM, by the addition of appropriate aliquots of a 1 M CaCl2
stock (in 10 mM TES), pH 7.4, and after incubation on ice for ;1 h, the
suspension centrifuged as above. The resulting pellets and supernatants were
analyzed by electrophoresis and immunoblot.
Expression of rabbit skeletal recombinant CSQ
Rabbit skeletal calsequestrin was subcloned into a pGEX5x1 vector (BamHI
at the 59 end and XhoI at the 39 end), containing an N-terminal GST tag.
Calsequestrin was expressed as GST fusion proteins in Escherichia coli
strain BL21DE3 colonies and puriﬁed by glutathione Sepharose 4B
chromatography. A single colony was grown at 37C to an optical density
at 600 nm of ;0.5, and expression was induced by 0.5 mM isopropyl B-D-
thiogalactoside. Bacteria were pelleted and resuspended, the cell membrane
disrupted by lysozyme and French press, centrifuged, and supernatant
incubated with glutathione Sepharose 4B beads. After incubation,
calsequestrin was cleaved from the GST-glutathione Sepharose 4B complex
by incubation with Factor Xa for 4 h at 25C. CSQ was dialyzed against
either 20 mMMOPS, 150 mM KCl, and 1 mM CaCl2 (pH 7.4) or against cis
solutions (see Single Channel Recording and Analysis below).
Electrophoresis and immunoblot
SDS-PAGE was performed using the Laemmli buffer system (Laemmli,
1970), with 10% polyacrylamide gels, whereas immunoblot was as per
Towbin et al. (1992).
31P-NMR spectroscopy
CSQ phosphorylation status was determined using 31P-NMR spectroscopy.
All spectra were acquired on a Varian-Inova 500 spectrometer (Palo Alto,
CA), using a spectral width of 15,000 Hz, a pulse width of;15ms, a spectral
frequency of 202,421 MHz, and an acquisition time of 0.33 s. Samples were
kept at a constant temperature of 5C. CSQ samples for NMR spectroscopy
were prepared at a concentration of ;0.17 mM in an H2O solution contain-
ing 10% D2O/90% H2O. Phosphoric acid was used as an internal standard
(0 ppm).
Acid phosphatase and casein kinase II treatment
Dephosphorylation (by acid phosphatase treatment) and phosphorylation
(by casein kinase II) of recombinant CSQ (coupled to a GST-glutathione
Sepharose matrix) were undertaken as previously described (Cala and Jones,
1991). To remove enzymes, samples were washed with 10 vol of 20 mM
MOPS, 1 mM Ca21, and 150 mM KCl.
GST fusion protein afﬁnity chromatography
To determine whether triadin and junctin can bind to both phosphorylated
and dephosphorylated CSQ, GST fusion protein afﬁnity chromatography
was undertaken as described by Shin et al. (2000), with the following
changes. Solubilized junctional face membrane (in 0.1% triton X-100)
was added to both phosphorylated and dephosphorylated glutathione
Sepharose 4B bound CSQ-GST, in 20 mM MOPS, 150 mM NaCl, and
1 mM CaCl2.
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Single channel recording and analysis
Artiﬁcial planar bilayers separating two baths (cis and trans) were formed
as previously described (Beard et al., 2002; Laver et al., 1995). SR vesicles
(50 mg) were added to the cis solution so that the cytoplasmic surface of
the SR and RyRs faced the cis solution after incorporation into the lipid
bilayer. For SR vesicle incorporation, the solution compositions were as
follows: cis, 230 mM CsMS, 20 mM CsCl, 1 mM CaCl2, and 10 mM TES
(pH 7.4); and trans, 30mM CsMS, 20 mM CsCl, 1 mM CaCl2, and 10 mM
TES (pH 7.4). After incorporation of a channel, trans [Cs1] was raised
from 50 to 250 mM with the addition of 200 mM CsMS and the cis
solution was altered by the addition of 4.5 mM BAPTA (free [Ca21 ] ¼
100 nM) and 2 mM ATP. Single channel parameters were obtained using
the Channel 2 program (developed by P. W. Gage and M. Smith, John
Curtin School of Medical Research, Canberra, Australia). Channel activity
was assessed from a 30-s record, either from fractional mean current (I9F,
which is the average of all data points obtained during a recording period
divided by the maximum single channel current), relative mean current
(I9t/I9c, which is the fractional mean current under test conditions, divided by
the fractional mean current under control conditions), or open probability
(Po). All electrical potentials are expressed here using standard physio-
logical convention (i.e., cytoplasmic side relative to the luminal side at
virtual ground). Unless otherwise stated, single channel recordings were ob-
tained using a bilayer potential difference of /140 mV. Measurements
were carried out at 23 6 2C. Channel activity is also expressed as
relative Po to include data in which activity varied from ;0.01 to ;0.6 and
would more accurately reﬂect the population response in the intact ﬁber
(N ¼ 4–14).
Statistics
Average data are presented as mean 6 SE. The signiﬁcance of differences
between control and test values was tested using a Student’s t-test for paired
data or a sign test (Minium et al., 1993), as appropriate. A p-value of,0.05
was considered to be signiﬁcant.
RESULTS
Effects of varying luminal Ca21 concentration
between 1 and 5 mM
Upon increasing trans Ca21 from 1 to 5 mM, there was an
almost immediate and signiﬁcant increase in the fractional
mean current (I9F) of the channel, from 0.086 (60.01) to
0.186 (60.04) in six experiments (Fig. 1, B and F). A
secondary rise in channel activity was then observed to
always occur within 3 min of exposure to 5 mM trans Ca21,
with I9F increasing to 0.291 (60.03) (Fig. 1 C). The average
dissociation time due to 5 mM Ca21 (110 6 17 s) was
consistent with the time course of high Cs1 dissociation of
CSQ (89 6 15 s) (Beard et al., 2002). Perfusion of the trans
chamber to lower Ca21 from 5 to 1 mM Ca21 reduced
channel activity somewhat, but not to control levels, despite
observing channel activity for up to 12 min. Subsequent
addition of a ﬁnal concentration of 16 mg/ml trans CSQ
reduced channel activity to a level that was not signiﬁcantly
different from control (Fig. 1 E). Furthermore, 0.5 mg/ml
trans polyclonal anti-CSQ antibody (which inhibits RyR
activity only when CSQ is present) (Beard et al., 2002), was
added to one channel after CSQ addition and further reduced
channel activity (data not shown). These results are
consistent with ﬁrstly, an initial direct activation of the
RyR by luminal Ca21when it was increased from 1 to 5 mM,
and a further activation when the 5 mM trans Ca21
dissociated CSQ from the RyR/T/J complex. Secondly,
lowering [Ca21] from 5 to 1 mM reversed the direct
activation of the RyR, and addition of 16 mg/ml trans CSQ
FIGURE 1 Increasing transCa21 from 1 to
5 mM resulted in a biphasic RyR activation.
(A–E) Records of 2 s of single channel
activity. Single channel opening is upward
from zero current (solid line) to maximum
open conductance (dashed line). (A) Control,
with 1 mM trans Ca21; (B) 30 s after
increasing trans Ca21 to 5 mM; (C) 3 min
after increasing transCa21 to 5 mM; (D) after
perfusing the trans chamberwith 1mMCa21;
(E) addition of 16 mg/ml CSQ; (F) average
data (n¼ 5–6) for fractional mean current (I9F)
for conditions shown in panels A–E. (G)
Control, with 1 mM trans Ca21; (H) after per-
fusing the trans chamber with 5 mM Ca21,
after CSQdissociation; (I) 5min after addition
of 16mg/ml CSQ. AveragePo (n¼ 5) is given
to the right of panels G–I. Asterisks (*)
indicate average values signiﬁcantly (p ,
0.05, t-test) different from control, and double
asterisk (**) and double cross-hatch (##)
indicate average values signiﬁcantly different
(p , 0.05, t-test and sign test, respectively)
from the previous condition. Vm-ECs1 was
140mV for all records presented in Figs. 1, 2,
4, and 5, except where indicated.
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resulted in a further decline of activity, presumably by
allowing reassociation of CSQ with the RyR/T/J complex
(possible once trans Ca21 had been restored to 1 mM).
Although data are only shown at 140 mV, similar effects
were obtained at 40 mV in all experiments.
In a second set of experiments CSQ was dissociated from
the RyR/T/J complex, after incorporation, by either in-
creasing [Cs1] to 500 mM or increasing trans Ca21 to 5 mM.
A late irreversible increase in activity was seen with CSQ
dissociation using both Cs1 and Ca21 dissociation. There
was also an immediate increase in activity with 5 mM Ca21
(data not shown). The trans chamber was then perfused with
solution containing 5 mM Ca21 to remove dissociated CSQ
from the chamber (Fig. 1 H). Subsequent addition of 16 mg/
ml exogenous CSQ did not signiﬁcantly reduce channel
activity, despite incubation for 7 min (Fig. 1 I). These data
illustrate that 5 mM Ca21 can both dissociate and prevent
reassociation of CSQ to the RyR/T/J complex. CSQ slowly
dissociated from channels exposed to 4 mM trans Ca21. If
channels were maintained in 4 mM trans Ca21, (Fig. 2, left
panels), the immediate Ca21 activation was followed in ﬁve
out of six channels, by a late activation observed after
;9 min (where I9F rose from 0.147 6 0.05 to 0.285 6 0.04)
(Fig. 2, C and F, left panels). Unlike 5 mMCa21 dissociation
(Fig. 1), no secondary change in channel activity was ob-
served within 3 min (Fig. 2 F, left panel). Replacement of
control trans Ca21 (1 mM) could only partially remove the
activation induced by prolonged exposure to 4 mM Ca21,
and in one out of one channel, 16 mg/ml exogenous CSQ
returned channel activity to levels similar to control (Fig. 2,
D and E, left panels).
Exposing RyRs to 2 or 3 mM trans Ca21 resulted in a fast
phase of RyR activation, but not the late phase within the time
frame of the experiment (Fig. 2, middle and right panels). I9F
increased almost immediately from control levels (I9F ¼
0.13236 0.02 to 0.30176 0.03; Fig. 2 F,middle panel) with
no further increase during incubation in 3 mM Ca21 for up to
18 min (Fig. 2, A–C,middle panel). Similarly, upon exposure
to 2 mM trans Ca21, channel activity rose immediately from
control levels (I9F ¼ 0.083 6 0.01 to 0.153 6 0.02; Fig. 2 F,
right panel). No further rise in activity was observed, despite
incubation in 2 mM Ca21 in one channel for up to 15 min.
Reperfusion of the trans chamber with 1 mM Ca21 restored
activity to control levels in both experiments (I9F ¼ 0.081 6
FIGURE 2 Extended exposure to trans Ca21 of 4 mM, and not 2 or 3 mM, resulted in a biphasic RyR activation. (A–E) Records of 2 s of single channel
activity. Single channel opening is upward from zero current (solid line) to maximum open conductance (dashed line) for the left panels, and downwards from
zero current (solid line) to maximum open conductance (dashed line) for the middle and right panels. (A) Control, with 1 mM trans Ca21; (B) 30 s after
increasing trans Ca21 to 4 mM (left panel), 3 mM (middle panel), and 2 mM (right panel); (C) 3 min (middle and right panels) and 9 min (left panel) after
increasing trans Ca21 to 4, 3, or 2 mM; (D) after perfusing trans chamber with 1 mM Ca21; (E) addition of 16 mg/ml CSQ; (F) average and individual data
(n¼ 4–8 for A–D and n¼ 1 for E) for fractional mean current (I9F), at [Ca21]s listed under the graph (left panel) or for conditions shown in panels A–D (middle,
right panels). Asterisks (*) indicate average values signiﬁcantly (p , 0.05, t-test) different from control, and double asterisk (**) and double cross-hatch
(##) indicate average values signiﬁcantly different (p, 0.05, t-test and sign test, respectively) from the previous condition. Vm-ECs1was140 mV for left panel
and 40 mV for middle and right panels.
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0.01 and 0.140 6 0.02 for channels previously exposed to 2
and 3 mM Ca21, respectively; Fig. 2, D and F). This shows
that the activity increase upon raising [Ca21] to 2 or 3mMwas
fully reversible (Fig. 2 D, middle and right panels), and
suggested that 2 or 3 mM Ca21 did not dissociate a signiﬁ-
cant proportion of CSQ from the RyR/T/J complex within
15–18 min.
The luminal Ca21 dependence of CSQ dissociation from
junctional face membrane was followed using SDS-PAGE.
Comparison of native SR vesicles (used in bilayer experi-
ments) and solubilized junctional facemembrane (used in this
section) have shown that the relative amounts of RyR, CSQ,
triadin, and junctin are the same in both preparations (Beard,
2003). Thus solubilization per se does not dissociate the
quaternary complex. Exposure of junctional face membrane
to 1 or 2 mMCa21 did not detach CSQ (Fig. 3, A and B, lanes
2–5), shown by Coomassie stain (Fig. 3 A), and immunoblot
with monocolonal VIIID12 anti-CSQ antibody (Fig. 3 B).
There was a signiﬁcant band at 55 kDa (the apparent
molecular weight of CSQ) in the original junctional face
membrane (Fig. 3, A and B, lane 1) and in the pellet, but not in
the supernatant, from the solubilized fractions after exposure
to either 1 or 2 mMCa21 [Ca21] (Fig. 3, A and B, lanes 2–5).
In contrast, 4, 5, and 10 mM Ca21 resulted in signiﬁcant
dissociation of CSQ from the junctional face membrane,
indicated by increasing amounts of CSQ in the supernatant
(Fig. 3, A and B, lanes 9, 11, and 13), and reduced (Fig. 3, A
andB, lane 8) or undetectable amounts in themembrane pellet
(Fig. 3, A and B, lanes 10 and 12). CSQ dissociated by 3 mM
Ca21 was undetectable (Fig. 3, A and B, lane 7), with the
proﬁle of the JFM and membrane pellet essentially identical
(Fig. 3, A and B, lanes 1 and 6). It is unlikely that a small
dissociation that might occur with 3mMCa21would alter the
regulatory effect onRyRchannels in lipid bilayer experiments
(Fig. 2). This dissociation data conﬁrmed our interpretation of
the single channel data, i.e., that CSQ was attached to RyRs
in the lipid bilayers under control conditions (1 mM Ca21),
that 2 and 3 mM Ca21 did not induce a CSQ dissociation-
dependent RyR activation, and that $4 mM Ca21 can
dissociate signiﬁcant amounts of CSQ from the RyR/T/J
complex. From both biochemical and lipid bilayer data, it
appears that 4 mM Ca21 is the minimal Ca21 concentration
required for CSQ dissociation and that dissociation critically
depends on a [Ca21] in the vicinity of 4 mM.
Changes in RyR activity caused by varying
luminal Ca21 between 1 and 5 mM
Native RyRs were incorporated into bilayers in the presence
of 1 mM transCa21, [Ca21] was then increased to 1.5, 2, 2.5,
3, and 5 mM in a stepwise fashion (Fig. 4), and channel
activity was followed at both positive and negative potentials.
For CSQ-attached (CSQ(1)) RyRs, currents were ana-
lyzed within 1 min of exposure to the increased [Ca21] to
avoid any effects of CSQ dissociation. However, in
agreement with results presented above (Fig. 2), channels
exposed to 1.5–3mMCa21 did not show a secondary increase
in activity under these conditions for up to 18 min, again
indicating that 1–3 mM luminal Ca21 did not dissociate CSQ
during this period. For experiments examining increases in
luminal Ca21 to 1.5–3 mM, CSQ-depleted (CSQ ())
channels were obtained increasing trans ionic strength before
trans [Ca21] was raised. The increase in ionic strength
effectively dissociatesCSQ from theRyR (Beard et al., 2002).
The trans Cs1 was increased from 250 to 500 mM and
maintained at that concentration until an increase in channel
activity was observed (89 6 15 s), indicating CSQ disso-
ciation (Beard et al., 2002). Once activity increased and re-
mained stable for 1 min, trans [Cs1] was restored to 250 mM
by perfusion. It should be noted that returning to 250 mM
Cs1 (control conditions) did not restore control RyR activity,
as expected if CSQ had been dissociated from the RyR/T/J
complex. For experiments with 5 mM Ca21, the high trans
Ca21 itself was used to dissociate CSQ, and activity after the
FIGURE 3 Only [Ca21]$4 mM can dissociate CSQ from the solubilized
junctional face membrane. (A) Ten percent SDS polyacrylamide gel
showing the original junctional face membrane pellet (JFM), insoluble
junctional face membrane pellet (P), and solubilized supernatant (S), after
the junctional face membrane was exposed to 1, 2, 3, 4, 5, or 10 mM Ca21.
CSQwas absent in the solubilized sample (S, lanes 3 and 5) after exposure to
1 or 2 mMCa21, with the gel proﬁle of the insoluble pellet (P, lanes 2 and 4)
being identical to the original junctional face membrane sample (JFM, lane
1). Only trace amounts of CSQ were found in the solubilized sample (S, lane
7) after incubation with 3 mM Ca21, leaving the proﬁles of the original
junctional face membrane and the insoluble pellet (compare lanes 1 and 6)
virtually identical. In contrast, increasing amounts of CSQ were dissociated
from the original junctional face membrane sample by exposure to 4, 5, and
10 mMCa21 (S, lanes 9, 11, and 13) with signiﬁcantly reduced (P, lane 8) or
undetectable levels of CSQ observed in the insoluble pellet (P, lanes 10 and
12). (B) Immunoblot of protein products shown in panel A, immunoprobed
with VIIID12 monoclonal anti-CSQ antibody. Approximate position of the
molecular weight markers are indicated to the left of lane 1 in panel A, with
CSQ indicated by the arrows. As [Ca21] was kept at 1 mM throughout the
CSQ puriﬁcation procedure, no additional Ca21 was added to the 1-mM
sample. The following amount of protein was added to the appropriate lanes;
50 mg original junctional face membrane, 40 mg pellet, and 10 ml solubilized
supernatant (which equates to 2.7 mg in lane 9, 3.3 mg in lane 11, and 4.7 mg
in lane 13). As a protein concentration cannot be determined for the
supernatants obtained after 1, 2, and 3 mM Ca21 extraction, an equivolume
(10 ml) of all supernatant fractions was loaded for both the Coomassie
stained gel and the immunoblot.
3448 Beard et al.
Biophysical Journal 88(5) 3444–3454
secondary increase (analyzed 3 min after exposure to 5 mM
Ca21), was used as the measure of the response of channel
activity in the absence of CSQ. Channel activity is reported as
relative Po, i.e., Po under test conditions (2–5 mM) relative to
Po under control (1 mM Ca
21) conditions. Removal of CSQ
made RyRs less responsive to increasing trans [Ca21] at each
[Ca21] tested (Fig. 4), with signiﬁcant differences in relative
Po seen at 2, 3, and 5 mM trans Ca
21. It should be noted that
although absolute channel Po under control conditions was
higher for CSQ() RyRs than for CSQ(1) RyRs (0.146 0.02
and 0.09 6 0.01, respectively), due to the removal of CSQs
inhibiting effect, CSQ(1) channels were more responsive to
changes in [Ca21] from 1 mM than CSQ() RyRs (Fig. 4).
The apparently smaller increase in channel activity at 5 mM
Ca21 compared with 3 mM Ca21in both CSQ(1) and
CSQ() channels was not explored further, but is indicative
of a small decline in activation seen at higher Ca21
concentrations and is perhaps due to a separate inhibitory
mechanism (Ching et al., 2000; Tripathy andMeissner, 1996).
Together, the data clearly demonstrate that CSQ ampliﬁed the
activating effect of luminal [Ca21] between 1 and 5 mM.
Determination of CSQs phosphorylation status
The phosphorylation status of the isolated CSQ was
determined by both 31P-NMR analysis and immunoblot
with anti-phosphothreonine. The 31P-NMR analysis in-
dicated that CSQ from rabbit skeletal muscle was phosphor-
ylated (Fig. 5 A, top trace). In the spectra, the horizontal axis
corresponds to a chemical shift (ppm), and reﬂects the
environment experienced by the phosphorous atoms. The
original CSQ sample (top trace) displays a resonance peak at
;0.2 ppm, suggesting that CSQ is at least in part
phosphorylated. CSQ, therefore, is probably phosphorylated
in vivo as it is unlikely that CSQ underwent autophosphor-
ylation during the isolation procedure as ATP was absent
from all isolation media.
The appearance of a broad resonance peak, at between
1.5 and2.8 ppm (arrow, top trace) in the phosphorylated
sample, suggests that the phosphorous atoms may reside in
an aggregated form of CSQ. Indeed, protein precipitation
was observed after NMR analysis, suggesting that some
CSQ aggregated during the 24-h testing period. This NMR
data show clearly that CSQ was phosphorylated but does not
allow determination of the number of phosphorylated res-
idues.
After dephosphorylation by acid phosphatase treatment
and subsequent dialysis to remove free phosphorous, the
peaks observed in the phosphorylated sample of CSQ at
;0.2 and between1.5 and2.8 ppm (Fig. 5 A, arrows, top
trace) disappeared. The appearance of a small peak near
1.2 ppm (arrow, bottom trace), may be explained by
residual (free) phosphorus atoms in the sample, most
probably due to incomplete dialysis of the CSQ sample
after dephosphorylation. Nevertheless, the dephosphorylated
CSQ sample contained at least 10 times less phosphorus than
the phosphorylated CSQ sample (indicated by the area under
each spectrum).
As Thr353 is phosphorylated in rabbit skeletal CSQ, (Cala
and Jones, 1991) both the original and acid phosphatase-
treated CSQ samples were probed with a polyclonal anti-
phosphothreonine antibody. Only the native CSQ and not the
dephosphorylated CSQ could be detected by this antibody
(Fig. 5 B). This observation conﬁrms the NMR data showing
that isolated CSQ is in a phosphorylated form, and can be
signiﬁcantly dephosphorylated by acid phosphatase treat-
ment.
Native RyR regulation by phosphorylated and
dephosphorylated CSQ
The actions of both phosphorylated and dephosphorylated
CSQ on native skeletal RyRs were examined under
physiological Ca21 conditions (1 mM trans Ca21). RyRs
were exposed to 500 mM trans Cs1 to dissociate endog-
enous CSQ, and this procedure resulted in a rise in Po at
positive potentials (Fig. 5, C and D, middle panel). After
subsequent perfusion of the trans chamber with 250 mM
Cs1, 16 mg/ml of phosphorylated CSQ was added (Fig. 5 C,
bottom panel). As seen previously (Figs. 1 and 2), phos-
phorylated CSQ signiﬁcantly reduced channel Po (Fig. 5 C).
FIGURE 4 RyR responses to changes in luminal [Ca21] between 1 and
5 mM, in the presence and absence of CSQ. Experimental conditions: cis
(mM) 250 Cs1, 2 ATP (activating), and 1 nM Ca21(subactivating); trans
(mM) 250 Cs1, 1–5 Ca21. Trans [Ca21] was altered by aliquot additions of
200 mM stock Ca21 ([Ca21] determined by a Ca21 electrode). CSQ was
dissociated from RyRs before increasing [Ca21] by exposure to 500 mM
Cs1, or to high [Ca21] (in the case of the data obtained at 5 mM Ca21). Each
data point is the mean relative open probability (relative Po), which is test Po
(2–5 mM Ca21) relative to control Po (1 mM), for RyRs in the absence
(CSQ(); n) and presence (CSQ(1);:) of CSQ. The bars are means6 SE
for n ¼ 4–14. Absolute mean Po values for control activities are listed in the
Results section. The inset chart shows relative Po changes at luminal Ca
21
from 1 to 2.0 mM Ca21 in more detail. Asterisks (*) indicate average values
signiﬁcantly different from control (p . 0.05, t-test).
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Similarly, reassociation of 16 mg/ml of dephosphorylated
CSQ also reduced channel activity to control (predissocia-
tion) levels (Fig. 5 D). Similar inhibitory effects of phos-
phorylated and dephosphorylated CSQ were seen at 40
mV. To ascertain whether the addition of exogenous CSQ
buffered [Ca21]free (and lower it signiﬁcantly from 1 mM),
the [Ca21] free was measured in the absence and presence of
CSQ using a Ca21 electrode. No signiﬁcant difference in
[Ca21]free was detected.
The phosphorylation status of CSQ did not inﬂuence its
ability to inhibit native RyRs at 1 mM trans Ca21. Phos-
phorylated CSQ decreased I9F relative to postdissociation
activity to 0.51 6 0.10 (N ¼ 16), whereas dephosphory-
lated CSQ decreased relative I9F to 0.43 6 0.15 (N ¼ 8).
Apparently, altering the phosphorylation status of exogenous
CSQ did not alter its functional interaction with the native
RyR/T/J complex, or the degree of inhibition it imposed.
CSQ interactions with triadin and junction
Determination of whether phosphorylation of CSQ altered its
binding to triadin and junctin was carried out using GST
fusion protein afﬁnity chromatography. GST-tagged CSQ
was bound to glutathione Sepharose 4B matrix, and was
experimentally phosphorylated or dephosphorylated (see
Methods) in situ. Only the phosphorylated CSQ sample was
detectably phosphorylated, as determined by anti-phospho-
threonine immunoblot (see Methods; data not shown).
Solubilized junctional face membrane (in 0.1% triton
X-100) was applied to either phosphorylated or dephosphory-
lated GST-tagged CSQ under near physiological conditions
(1 mM CaCl2, 150 mM NaCl), and after a 2-h incubation,
unbound proteins were washed and separated from the
protein-bound CSQ-GST-glutathione Sepharose complex.
This complex was subsequently collected by centrifugation.
Junctional face membrane proteins that interacted with GST-
tagged CSQ were separated by SDS-PAGE and immuno-
probed with anti-triadin and anti-junctin after Western blot
(Fig. 6). The results indicated that CSQ will still form a
complex with triadin and junctin regardless of its phosphor-
ylation status, as both triadin and junctin interacted with both
phosphorylated and dephosphorylated CSQ (Fig. 6).
FIGURE 5 Phosphorylation status of CSQ in
skeletal muscle; both exogenous phosphorylated
and dephosphorylated CSQ inhibit CSQ() RyRs.
(A) 31P-NMR spectrum. The resonances for
phosphorylated (P) CSQ, from the original CSQ
sample are indicated with arrows in the top trace,
whereas residual unbound phosphorous in the
dephosphorylated (deP) CSQ, is indicated with
an arrow in the bottom trace; (B) Immunoblot of
20 mg P-CSQ and deP-CSQ, immunoprobed with
polyclonal antibody anti-phosphothreonine, with
the approximate position of molecular weight
markers indicated next to the immunoblot; (C and
D) changes in CSQ() RyR activity after addition
of exogenous P-CSQ (C) and deP CSQ (D). In
panels C and D, records of 2 s of single channel
activity where channel opening is upward from
zero current (solid line) to maximum open
conductance (dashed line). The top traces show
control (Con) activity with 250 mM trans Cs1; the
middle traces shows activity after increasing trans
Cs1 to 500 mM with CsMS (Diss); the bottom
trace shows addition of 16 mg/ml of P-CSQ (C) or
DeP-CSQ (D), after trans perfusion with 250 mM
Cs1. Average channel Po values (with means 6
SE) are given to the right of traces in panel C (n ¼
6) and panel D (n ¼ 5). Asterisks (*) indicate
average values signiﬁcantly different from control
and double asterisks (**) indicate values different
from the previous condition (p , 0.05, t-test).
FIGURE 6 Interactions of triadin and junctin with CSQ are independent
of phosphorylation status. Western blot, after 10% SDS-PAGE, of the
GST-CSQ coupled to glutathione Sepharose 4B before (lanes 2 and 4) and
after (lanes 3 and 5) exposure to solubilized junctional face membrane (JFM;
lane 1). Blot was immunoprobed with anti-triadin and anti-junctin. Both
phosphorylated (P-CSQ; lanes 2 and 3) and dephosphorylated (deP-CSQ;
lanes 4 and 5) CSQ could bind triadin and junctin (lanes 3 and 5) under close
to physiological conditions (1 mM Ca21, 150 mM NaCl).
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DISCUSSION
Novel observations on the Ca21 dependence of the
association between CSQ and the RyR, and the effect of
CSQ on the luminal Ca21 dependence of RyR activity, are
described. Using two different techniques, we show that
CSQ is associated with the RyR when the luminal [Ca21] is
maintained at the physiological level of ;1 mM. Further-
more, CSQ remains associated with the RyR/T/J complex
when luminal Ca21 is increased from 1 to 3 mM, but
dissociates at 4 and 5 mM (and cannot reassociate at 5 mM
Ca21). In addition, this is the ﬁrst report of the effects of high
luminal [Ca21] on skeletal RyR activity under conditions
in which CSQ would have remained associated with the
RyR/T/J complex after RyRs were incorporated into
bilayers. We show that under these conditions, channel
activity increases as luminal Ca21 is increased and that the
response of the RyR to small increases in luminal [Ca21]
from 1 to 5 mM is ampliﬁed by CSQ. Finally, we show that
CSQ in native SR is phosphorylated and that both a physical
and functional coupling of CSQ with native RyR channels
and with triadin and junctin is independent of CSQ phos-
phorylation.
Is CSQ associated with the RyR/T/J complex
under physiological conditions?
If CSQ plays an active role in communicating luminal
[Ca21] to the RyR in vivo, it must be physically coupled
either directly or indirectly to the RyR under normal
physiological conditions. Using both biochemical (Fig. 3)
and electrophysiological techniques (Figs. 1 and 2), we show
that CSQ is associated with the junctional face membrane
when the luminal [Ca21] is;1 mM, i.e., the free [Ca21] that
is considered to exist in the lumen of the SR in vivo (Fryer
and Stephenson, 1996). In addition, electron micrographs of
terminal cisternae, and electron tomography of frozen
hydrated triad junctions from skeletal muscle (ﬁxed under
physiological conditions), show CSQ located close to the
RyR, suggesting that under physiological conditions, CSQ is
associated with the RyR (Franzini-Armstrong, 1973; Wa-
genknecht et al., 2002). This is not unexpected because CSQ
association with triadin and junctin in skeletal muscle
requires Ca21 (Guo and Campbell, 1995; Wang et al.,
1998). However, other conﬂicting evidence suggests that
binding of solubilized skeletal SR to a GST-CSQ fusion
protein is gradually reduced as Ca21 increased from 0 to
5 mM, with maximal binding occurring at 0 mM Ca21, lead-
ing to the conclusion that CSQ may not associate with the
skeletal RyR/T/J complex in the presence of physiological
(1 mM) Ca21 (Shin et al., 2000). It should be noted that
data presented by Shin et al. (2000) show signiﬁcant CSQ
association with the solubilized SR at 1 mM Ca21. In the
light of our data (Figs. 1–3 and 6) and those of Guo and
Campbell (1995) and Costello et al. (1986), skeletal CSQ
association with triadin and junctin under physiological
[Ca21] seems to be likely.
How does high Ca21 dissociate CSQ from the
RyR/T/J complex?
It is likely that the ability of CSQ to associate with and
dissociate from triadin and junctin at different [Ca21],
depends on the structure of the CSQ protein, which is
strongly Ca21 dependent. It is not clear how high [Ca21]
dissociates CSQ from the RyR/T/J complex. At low [Ca21],
CSQ assumes a mostly random coil structure, with a-helical
content increasing as Ca21 binds (Ikemoto et al., 1972, 1974;
Ostwald et al., 1974). To form dimers and polymers, both
skeletal and cardiac CSQ require Ca21, presumably above
10 mM. High [Ca21] ($5 mM) dissociates CSQ from the
junctional face membrane (this study) and has been
successfully used to selectively elute recombinant CSQ
from phenyl-Sepharose afﬁnity matrix (Cala and Jones,
1983). Recent studies with the cardiac RyR show that
exposure of the reconstituted quaternary complex to 5 mM
luminal Ca21 resulted in channel activation due to CSQ
dissociation (Gyo¨rke et al., 2004). Additionally, increasing
[Ca21] to $5 mM decreases the stokes radius and increases
the apparent compaction of CSQ (Cozens and Reithmeier,
1984), and results in CSQ aggregation (N. A. Beard and A. F.
Dulhunty, unpublished data; Park et al., 2003). As the [Ca21]
rises, hydrophobic side chains are buried within the polymer,
reducing the ability of CSQ to bind to other proteins
(Mitchell et al., 1988). This is suggestive of a somewhat
‘‘supercompacted’’ CSQ within the polymer (Beard et al.,
2004). Supercompaction of CSQ upon exposure to in-
creasing luminal [Ca21] may disrupt the interactions with
triadin and junctin (and indeed the RyR), allowing selective
dissociation of CSQ.
Role for CSQ in regulating RyRs at 1–5 mM
luminal Ca21
Ikemoto et al. (1972) and Ostwald et al. (1974) reported
changes in CSQ conformation occurring within the range of
[Ca21] tested here. Alterations in protein conformation with
luminal [Ca21] changes between 0.1 and 3 mM have been
postulated to increase SRCa21 release rate constants (Donoso
et al., 1995). In this study, the channel response to varying
[Ca21] between 1 and 5 mM was ampliﬁed in the presence
of CSQ. The change in activity observed upon exposure to
2 mMCa21 cannot be attributed to an effect of CSQ dissocia-
tion, as exposure of junctional face membrane to 2 mM Ca21
does not dissociate CSQ (Fig. 3). It is possible that regulation
of RyRs by luminal Ca21 is partly due to Ca21-dependent
changes in CSQ conformation that do not result in CSQ disso-
ciation (He et al., 1993; Ikemoto et al., 1989).
In cardiac muscle, increasing luminal [Ca21] induced an
increase in activity in native, but not puriﬁed RyRs (Gyo¨rke
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et al., 2004). Only restoration of the quaternary complex, by
adding exogenous triadin, junctin, and CSQ (but not by
adding triadin and junctin alone), could restore RyR
responsiveness to luminal Ca21 (Gyo¨rke et al., 2004).
Although in the absence of CSQ, increasing luminal [Ca21]
resulted in RyR activation, we show that in skeletal muscle,
RyR responsiveness to increased luminal [Ca21] was sub-
stantially augmented by the presence of CSQ. Both studies
(Fig. 4; Gyo¨rke et al., 2004) provide evidence for the role of
CSQ (as part of an intact quaternary complex) as a luminal
Ca21 sensor.
CSQ activation versus CSQ inhibition of RyRs
The reported effects of CSQ on RyRs vary between
laboratories and preparations, as seen with the response of
the RyR to phosphorylated and dephosphorylated CSQ.
With physiological luminal [Ca21], the ability of CSQ to
inhibit native skeletal RyRs was independent of phosphor-
ylation (Fig. 5). In contrast, Szegedi et al. (1999) showed that
CSQ activates puriﬁed skeletal RyRs only when it is
dephosphorylated and we have conﬁrmed these ﬁndings in
our laboratory (N. A. Beard, unpublished data). Thus, the
differences in RyR regulation observed in these two studies
can be explained by the different preparations used; the 3-
[(3-Cholamidopropyl)Dimethyl-Ammonio]-1-Propanesulfo-
nate solubilized and puriﬁed RyR (with presumably no
signiﬁcant amounts of accessory proteins triadin and junctin
present) in Szegedi’s study (and our observations), and the
native RyR, with triadin and junctin present (in this study).
Although we cannot discount that another unknown
accessory protein found within the SR lumen may be
responsible for anchoring CSQ to the RyR in the native
preparation, the only two proteins known to bind both CSQ
and the RyR in the lumen are triadin and junctin.
In addition, the reported differences in CSQ regulation of
RyRs support the hypothesis that CSQ modulates RyR activ-
ity via two mechanisms; ﬁrstly, by inducing RyR inhibition
through interactions with triadin and junctin in a phosphory-
lation-independent manner (this study), and secondly, by
binding directly to the RyR (Herzog et al., 2000) and acti-
vating the channel in a phosphorylation-dependent manner,
as shown by Szegedi et al. (1999). Whether or not both
mechanisms of CSQ regulation operate in native RyRs in
vivo is unknown. If so, the reported CSQ activation induced
by a direct RyR-CSQ interaction is overshadowed by the
triadin/junctin mediated CSQ inhibition, seen as an overall
inhibition of the channel.
Phosphorylation as an in vivo modulator of CSQ
regulation of RyRs?
Regulation of RyRs by cyclic phosphorylation/dephosphor-
ylation of CSQ in vivo depends on whether CSQ is
phosphorylated before luminal segregation, or after targeting
to the lumen. This, in turn, depends on the location of
speciﬁc kinases responsible for CSQ phosphorylation, and
whether or not ATP could be transported into the lumen
of the SR. It is not known which kinase speciﬁcally
phosphorylates CSQ in vivo, or whether such kinases are
present in the SR lumen (or indeed whether CSQ is
phosphorylated inside the lumen). Casein kinase II phos-
phorylates Thr353 in skeletal CSQ (Cala and Jones, 1991). To
date, the presence of casein kinase II within the SR lumen
has been inferred, but not proven (Shoshan-Barmatz et al.,
1996). Thr353 or another phosphorylatable residue may also
be phosphorylated by other kinases, which might be present
in the lumen. CSQ has also been identiﬁed as a potentially
good substrate for casein kinase I and e protein kinase C, but
current evidence suggests that these kinases reside only in
the cytoplasm and not within the SR lumen (Rodriguez et al.,
1999; Salvatori et al., 1994). CSQ is phosphorylated when
isolated from muscle homogenates (Fig. 5 B) and this ob-
servation shows that CSQ in the SR lumen is phosphory-
lated. Cala and Jones (1991) found that rabbit skeletal CSQ
was not isolated in its phosphorylated form; Campbell and
Shamoo (1980) show that CSQ can be phosphorylated in
skeletal SR muscle preparations, whereas Varsanyi and
Heilmeyer (1980) report that CSQ is capable of autophos-
phorylation and the isolated calsequestrin from skeletal
muscle can be obtained in fully or partially phosphorylated
form (Varsanyi and Heilmeyer, 1979). Recently, O’Brian
et al. (2002) reported that presumably phosphorylation and
glycosylation processes are involved in both common and
distinct cellular compartmentation of the calsequestrin
isoforms.
Physiological implications
Taken together, these results show that luminal Ca21 has two
actions on RyR channels. Firstly, Ca21 can bind to activation
sites, found on the RyR or an associated protein (when
luminal Ca21 is raised from 1 to $4 mM). Secondly, the
increase in luminal [Ca21] can consistently dissociate CSQ,
inducing a further signiﬁcant rise in RyR activity, and 5 mM
luminal Ca21 can prevent reassociation of CSQ with the
RyR/T/J complex. It is not likely that the dissociation of
CSQ from the junctional face membrane would be caused
by normal physiological changes in luminal [Ca21], and
therefore CSQ dissociation-induced changes in RyR activity
may not be of physiological importance. However, levels of
luminal Ca21 of;10 mM are obtained experimentally when
loading the SR to above-normal levels (Lamb et al., 2001),
and such loading leads to enhanced Ca21 release. The
contribution of CSQ dissociation from the junctional face
membrane in the SR to this increase in activity remains to be
investigated.
Although not investigated here, CSQ might inﬂuence RyR
function in response to changes in total luminal [Ca21] in
a similar manner to calmodulin (associated with cytoplasmic
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[Ca21]) (Meissner 1986; Plank et al., 1983; Rodney et al.,
2000; Tripathy et al., 1995; Xu and Meissner, 2004). Like
calmodulin, the effect of CSQ on RyR function may depend
on the Ca21 binding status of CSQ (and CSQ conformation),
which is likely to vary with changes in total luminal [Ca21]
(i.e., store loading). Changes in the amount of Ca21 bound to
CSQ could occur with only minor changes in the free [Ca21]
and might alter CSQ conformation without dissociation, thus
causing subtle changes in RyR activity or its response to
cytoplasmic ligands such as Ca21. Indeed, CSQ has been
implicated as a major luminal Ca21 sensor, whose presence
is required (along with triadin and junctin), to enhance RyR
responsiveness to changes in luminal Ca21 concentration
(this article; Gyo¨rke et al., 2004).
In conclusion, we ﬁnd that CSQ is associated with the
RyR/T/J complex when free luminal Ca21 is at a physiolog-
ical concentration of ;1 mM, and we provide novel data
showing that CSQ dissociates from the skeletal RyR
complex when the free [Ca21] increases to between 3 and
5 mM. The results show that CSQ sensitizes the RyR to
changes in free [Ca21] between 1 and 5 mM. Finally, we
show that although CSQ is most likely phosphorylated in
vivo, its ability to inhibit RyR activity does not depend on its
phosphorylation status. These data provide mounting
evidence that an intact quaternary complex between CSQ,
triadin, junction, and the RyR forms a signaling pathway that
communicates the luminal [Ca21] to the RyR channel.
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